-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Osaka, Japan - BRCA1 is a protein known for its role in hereditary breast cancer.
In a study published in Cell Reports, researchers at Osaka University found that protein phosphatase 1 (PP1) binds in the early stages of double-strand breaks and promotes repair through non-homologous end joining rather than homologous recombination.
The determination of which of these two pathways is used to repair double-strand breaks is carefully regulated by the cell in many different ways
The lead author of the study, Shin-Ya Isobe, explained: “Double-strand breaks that are not protected by the RIF1 protein complex are easily digested by other proteins, resulting in a single-stranded DNA that can be repaired by homologous recombination
To determine other factors that can help protect the newly broken DNA ends, the researchers used a technique called proteomics mass spectrometry to find out which proteins interact with RIF1
Senior author Chikashi Obuse explained: "We found that PP1 specifically binds to RIF1 at the end of the broken DNA.
Importantly, the interaction between PP1 and RIF1 helps prevent double-stranded DNA breaks from forming a single-stranded "tail", which is bound by the shield protein
"Our findings reveal a new mechanism for selecting a double-strand DNA break repair pathway that works early in the repair process," Isobe said
Given that the problem of double-strand break repair is a key feature of many cancers, knowing more about how cells decide which pathway to use to repair these damaged parts can provide important insights into the development of cancer
# # #
"Protein Phosphatase 1 acts as a RIF1 effector to suppress DSB resection prior to Shieldin action," was published in Cell Reports at DOI: https:/